OUT OF STOCK

MRP ₹275.00
Inclusive of all taxes
Get this at ₹225.50
Cart Total
₹0
*10 Capsule(s) in a Strip * Mkt: Hetero Healthcare Limited * Country of Origin: India * Delivery charges if applicable will be applied at checkout


INTRODUCTION

DBTERO 75MG CAPSULE contains Dabigatran etexilate which belongs to the group of medicines called Anticoagulants. It is used to prevent stroke, systemic embolism and reduction of vascular mortality in adult patients with atrial fibrillation and venous thromboembolic events in patients who have undergone orthopaedic surgery.

It is also used to treat acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and prevents recurrent deep vein thrombosis (DVT) and /or pulmonary embolism (PE). This medicine is also used in children to treat blood clots and to prevent blood clots from reoccurring.

Avoid taking DBTERO 75MG CAPSULE, if you currently have bleeding disorders, organ disease of the body that increases the risk of serious bleeding such as stomach ulcer, injury or bleeding in the brain, severely reduced kidney or liver function.

Before taking DBTERO 75MG CAPSULE, inform your doctor if you have increased bleeding risks such as s bone fracture, head injury or any injury requiring surgical treatment, lung or heart problems.

DBTERO 75MG CAPSULE is not recommended for use in pregnant and breastfeeding women. Consult your doctor before taking DBTERO 75MG CAPSULE.

Your doctor will prescribe the right dose depends on your child’s age body weight and disease condition. Consult your doctor before taking DBTERO 75MG CAPSULE.

The most common side effects of taking DBTERO 75MG CAPSULE are stomachache, indigestion, frequent loose or liquid bowel movements and or nausea. Consult your doctor if any of these above side effects gets worse.

USES OF DBTERO 75MG CAPSULE

It is used to:

  • prevent stroke, systemic embolism and reduction of vascular mortality in adult patients with atrial fibrillation
  • prevent venous thromboembolic events in patients who have undergone orthopaedic surgery
  • treat acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE)
  • prevent recurrent deep vein thrombosis (DVT) and /or pulmonary embolism (PE)
  • treat blood clots and to prevent blood clots from reoccurring (in children)

HOW DBTERO 75MG CAPSULE WORKS

DBTERO 75MG CAPSULE works by blocking thrombin (blood central clotting agent) that results in the prevention of blood clots thereby preventing the occurrence of stroke, heart attack, deep vein thrombosis and pulmonary embolism.

DIRECTIONS FOR USE

Take DBTERO 75MG CAPSULE as advised by your physician. Swallow DBTERO 75MG CAPSULE with a glass of water and do not chew or crush the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.

SIDE EFFECTS OF DBTERO 75MG CAPSULE

COMMON

  • bleeding (nose, stomach or bowel, from penis/vagina or urinary tract)
  • stomachache
  • indigestion
  • frequent loose or liquid bowel movements
  • nausea

UNCOMMON

  • bleeding (joint, from or after an injury or after an operation, from piles, from the rectum or in the brain)
  • haematoma, formation or bruising occurring after an operation
  • coughing of blood or blood stained sputum
  • allergic reactions
  • sudden change in color and appearance of the skin
  • itching
  • ulcer in the stomach or bowel
  • inflammation of the gullet and stomach
  • reflux of gastric juice into the gullet
  • vomiting
  • wound secretion (liquid exuding from the surgical wound)
  • yellowing of the skin or whites of the eyes (liver or blood problems)
  • difficulty in swallowing

RARE

  • sign of allergic skin reaction such as skin rash notable for dark red, raised, itchy bumps

Stop taking DBTERO 75MG CAPSULE and contact your doctor if you experience any of the following side effects:

  • signs of excessive bleeding such as exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling
  • serious allergic reaction which causes difficulty in breathing or dizziness

HOW TO MANAGE SIDE EFFECTS

Dizziness:

Try to rest and relax and get enough sleep. Try to avoid driving or operating any tools or machines while you are feeling dizzy. Limit your consumption of alcohol, as it can aggravate your dizziness. Consult and inform your doctor if the symptom does not improve.

Nausea and Vomiting:

Try to take DBTERO 75MG CAPSULE with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult your doctor if the symptom gets worse.

Indigestion:

Try to have smaller and more frequent meals and eat slowly. Try to reduce consumption of tea, coffee, cola or alcohol and lose weight if you are obese. Consult and inform your doctor if the symptom does not improve.

WARNING & PRECAUTIONS

PREGNANCY

DBTERO 75MG CAPSULE is not recommended for use in pregnant women. Consult your doctor before taking DBTERO 75MG CAPSULE.

BREASTFEEDING

DBTERO 75MG CAPSULE is not recommended for use in breastfeeding women. Consult your doctor before taking DBTERO 75MG CAPSULE.

DRIVING AND USING MACHINES

DBTERO 75MG CAPSULE has no known effects to affect the ability to drive or use machines. Consult your doctor before taking DBTERO 75MG CAPSULE.

ALCOHOL

Avoid Consumption of alcohol while taking DBTERO 75MG CAPSULE. Consult your doctor for advice.

KIDNEY

DBTERO 75MG CAPSULE is not recommended for use in patients with severely reduced kidney function. Consult your doctor before taking DBTERO 75MG CAPSULE.

LIVER

DBTERO 75MG CAPSULE is not recommended for use in patients with severe liver disease or reduced liver function. Consult your doctor for advice before taking DBTERO 75MG CAPSULE.

ALLERGY

Do not take DBTERO 75MG CAPSULE if you are allergic to Dabigatran etexilate or any of the other ingredients of this medicine.

LUNGS

DBTERO 75MG CAPSULE should be used with caution in patients with lung problems such as pulmonary embolism (blood clot in lungs). Consult your doctor before taking DBTERO 75MG CAPSULE.

HEART DISEASE

DBTERO 75MG CAPSULE is not recommended for use if you have received an artificial heart valve that requires permanent blood thinning. It should be used with caution in patients with heart problems such as heart attack, bacterial endocarditis (infection in the heart). Consult your doctor before taking DBTERO 75MG CAPSULE.

OTHERS

DBTERO 75MG CAPSULE is not recommended for use if you:

  • have bleeding problems

Before taking DBTERO 75MG CAPSULE, inform your doctor if you:

  • have increased bleeding risk such as surgical tissue removal (biopsy), serious injury (bone fracture, head injury or any injury requiring surgical treatment), inflammation of the gullet or stomach, reflux of gastric juice into the gullet
  • have symptoms of dehydration such as feeling thirsty and passing reduced amounts of dark-coloured (concentrated) or foaming urine

Use in pediatrics:

DBTERO 75MG CAPSULE is recommended for use in children and adolescents (from 8 to 18 years of age) to treat and reduce the risk of recurrence of blood clot disorder. Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before taking DBTERO 75MG CAPSULE.

Use in geriatrics:

DBTERO 75MG CAPSULE is used with caution in elderly patients (aged 75 years or above). Consult your doctor before taking DBTERO 75MG CAPSULE.

INTERACTIONS

A. Drug-Drug Interactions:

Before taking DBTERO 75MG CAPSULE, inform your doctor, if you are taking any of the following medicine:

  • aspirin (medicines used to reduce fever and relieves mild to moderate pain)
  • ibuprofen, naproxen, diclofenac (medicines used to reduce fever and relieve mild to moderate pain)
  • warfarin, phenprocoumon, acenocoumarol, heparin, clopidogrel, prasugrel, ticagrelor, rivaroxaban, acetylsalicylic acid (medicines used to reduce blood clotting)
  • medicines to treat fungal infections (Ex. ketoconazole, itraconazole)
  • medicines to treat abnormal heart beats (Ex. amiodarone, dronedarone, quinidine, verapamil)
  • medicines used to prevent organ rejection after transplantation (Ex. tacrolimus, cyclosporine)
  • glecaprevir and pibrentasvir (used to treat hepatitis C)
  • citalopram, dapoxetine, escitalopram fluoxetine, St. John’s wort, desvenlafaxine, duloxetine, levomilnacipran (used for depression)
  • rifampicin or clarithromycin (used for bacterial infection)
  • ritonavir (used for AIDS)
  • medicines used for epilepsy (Ex. carbamazepine, phenytoin)

Overdosage:

If you or anyone else accidentally takes too much of DBTERO 75MG CAPSULE, consult your doctor immediately or visit the nearby hospital.

SYNOPSIS

Drug :   Dabigatran etexilate
Pharmacological Category :   Anticoagulants
Therapeutic Indication :   Prevent stroke, systemic embolism and reduction of vascular mortality in adult patients with atrial fibrillation, Venous thromboembolic events in patients who have undergone orthopaedic surgery, Blood clot disorders
Dosage Forms :   Capsule, Tablet

MORE INFORMATION

  • Keep the medicine out of reach in children
  • Store DBTERO 75MG CAPSULE at room temperature

FAQs ABOUT DBTERO 75MG CAPSULE

What DBTERO 75MG CAPSULE is used for?

DBTERO 75MG CAPSULE is used to prevent stroke, systemic embolism and reduction of vascular mortality in adult patients with atrial fibrillation and venous thromboembolic events in patients who have undergone orthopaedic surgery.

How should DBTERO 75MG CAPSULE be taken?

Take DBTERO 75MG CAPSULE as advised by your physician. Swallow DBTERO 75MG CAPSULE with a glass of water and do not chew or crush the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.

What are the side effects of DBTERO 75MG CAPSULE?

The most common symptoms of taking DBTERO 75MG CAPSULE are stomachache, indigestion , frequent loose or liquid bowel movements and nausea. Consult your doctor if any of these above side effects gets worse.

What happens if you stop taking DBTERO 75MG CAPSULE?

Do not stop taking DBTERO 75MG CAPSULE without talking to your doctor first, because the risk of developing a blood clot could be higher if you stop treatment too early. Consult your doctor if you have any queries regarding stopping the medicine.

Is DBTERO 75MG CAPSULE safe to use in children?

DBTERO 75MG CAPSULE is recommended for use in children and adolescents (from 8 to 18 years of age) to treat and reduce the risk of recurrence of blood clot disorder. Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before taking DBTERO 75MG CAPSULE.

REFERENCES

1. KD. Tripathi. Drugs Affecting Coagulation, Bleeding and Thrombosis. Seventh edition. 2013. Page – 623.

2. Boehringer Ingelheim. Safety of Dabigatran Etexilate in Blood Clot Prevention in Children. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in June 2020] [Accessed on 30th May 2022] https://clinicaltrials.gov/ct2/show/NCT02197416

3. Eline A Dubois and Adam F Cohen. Dabigatran etexilate. NIH National Library of Medicine, National center for biotechnology information. PMC PubMed Central. July 2010. [Accessed on 30th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909802/

4. Teerapat Nantsupawat, Suthipong Soontrapa, Nopakoon Nantsupawat, David Sotello, Saranapoom Klomjit, Selcuk Adabag and Alejandro Perez-Verdia. Risk factors and prevention of dabigatran-related gastrointestinal bleeding in patients with atrial fibrillation. NIH National Library of Medicine, National center for biotechnology information. PMC PubMed Central. February 2018. [Accessed on 30th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828263/

5. Boehringer Ingelheim Pharmaceuticals, Inc. PRADAXA. [Revised in June 2021] [Accessed on 30th May 2022] https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf

6. Boehringer Ingelheim International GmbH. Electronic medicines compendium (EMC). [Revised in January 2021] [Accessed on 30th May 2022] https://www.medicines.org.uk/emc/files/pil.6228.pdf

7. Boehringer Ingelheim International GmbH. Electronic medicines compendium (EMC). [Revised in January 2021] [Accessed on 30th May 2022] https://www.medicines.org.uk/emc/files/pil.6229.pdf

8. Boehringer Ingelheim International GmbH. Electronic medicines compendium (EMC). [Revised in January 2021] [Accessed on 30th May 2022] https://www.medicines.org.uk/emc/files/pil.4703.pdf

9. Boehringer Ingelheim Pharmaceuticals, Inc. U.S. Food & Drug Administration (EMC). [Revised in November 2015] [Accessed on 30th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022512s028lbl.pdf

AUTHOR DETAILS

Written By Dr. Janet.C, Pharm.D
Last updated on 10 Nov 2022 | 09:56 AM(IST)

PRODUCT DETAILS
    Net Qty
    1 N
    Shelf Life
    720
    Item Weight
    17.5 g
    Ingredient
    Dabigatran 75 mg
    Hsn Code
    30049099
ALTERNATE BRANDS
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.